The Intradermal influenza vaccine is a novel flu vaccine administered through injection into the dermis to provide immune protection. Compared to traditional intramuscular vaccines, this vaccine targets surface antigens of the influenza virus, effectively stimulating the body's immune response and reducing the risk of infection.
This type of vaccine is particularly suitable for individuals who fear or cannot tolerate traditional injections, such as children, the elderly, or patients with bleeding disorders like hemophilia. The development of the Intradermal influenza vaccine aims to offer a gentler yet effective immunization method.
The Intradermal influenza vaccine is a live attenuated or split-virus vaccine primarily targeting hemagglutinin and neuraminidase proteins of the influenza virus. It utilizes antigen-presenting cells in the dermis, such as Langerhans cells, to present viral antigens to T lymphocytes, thereby activating humoral and cellular immune responses.
The vaccine's mechanism mainly includes: stimulating humoral immunity to produce neutralizing antibodies; activating memory T and B cells to provide long-term immune memory. This allows for cross-protection even if the virus strains mutate.
The Intradermal influenza vaccine is mainly used to prevent seasonal influenza in all age groups, especially high-risk populations. High-risk groups include: the elderly (65 years and older), young children, pregnant women, patients with chronic diseases (such as diabetes, cardiovascular diseases, lung diseases), and immunocompromised individuals.
Additionally, this vaccine can be used for individuals with severe allergic reactions or intolerance to traditional intramuscular vaccines. Physicians will evaluate whether the Intradermal influenza vaccine is suitable based on individual circumstances.
The Intradermal influenza vaccine must be administered by healthcare professionals under sterile conditions. Using a special micro-needle, the vaccine is injected into the dermis, usually in the forearm or shoulder area. The dose per injection is 0.1 mL, which is smaller than the 0.5 mL used in traditional intramuscular injections.
Generally, adults and children aged 3 years and above only require a single injection to provide protection for one flu season. For certain populations, such as immunocompromised individuals, multiple injections or booster shots may be necessary to ensure adequate immune response.
Additionally, the Intradermal influenza vaccine method reduces vaccine waste and increases vaccination rates, especially advantageous in resource-limited areas.
Like all vaccines, the Intradermal influenza vaccine may cause side effects, most of which are mild and temporary. Common side effects include redness, swelling, pain, or itching at the injection site, usually resolving within a few days.
In rare cases, systemic reactions such as low-grade fever, fatigue, headache, or muscle aches may occur, generally mild and lasting no more than 48 hours. Very rarely, allergic reactions such as throat swelling or difficulty breathing may happen, requiring immediate medical attention.
When using the Intradermal influenza vaccine, physicians will assess whether the patient has the following conditions to ensure safety:
Additionally, patients should inform their doctor if they have blood disorders, immune deficiencies, or are taking immunosuppressants, to allow for the best evaluation.
The Intradermal influenza vaccine may interact with other medications or treatments, affecting efficacy or increasing side effect risks. Patients should inform their healthcare provider of all medications they are using, including:
Furthermore, simultaneous administration with other vaccines (such as adenovirus vaccines) may impact immune response; doctors might recommend spacing out the vaccinations.
Clinical trial data demonstrate that the Intradermal influenza vaccine is effective in preventing seasonal influenza. Studies show that it significantly reduces the incidence of influenza in high-risk populations and effectively prevents influenza-related complications such as pneumonia and bronchitis.
Additionally, the vaccine has shown good immunogenicity in the elderly, stimulating sufficient antibody production for long-term protection. Multiple studies confirm that the Intradermal influenza vaccine performs comparably to traditional intramuscular vaccines, with some evidence suggesting even better efficacy in certain groups.
If the Intradermal influenza vaccine is unsuitable or unavailable, physicians may recommend the following alternatives:
Each vaccine has its advantages and disadvantages. The doctor will choose the most appropriate type based on the patient's specific situation.
Before receiving the intradermal flu vaccine, it is recommended that patients wear short-sleeved clothing for easy access. They should ensure the injection site is clean and free of injury, and avoid spicy or hot foods 24 hours prior to vaccination to prevent affecting the immune response.
What are the side effects of the intradermal flu vaccine?Common side effects include redness, swelling, and pain at the injection site, typically appearing within 24 to 48 hours and resolving within a few days. A small number of patients may experience mild fever or fatigue, but these effects are usually mild and temporary.
What should I watch out for after receiving the intradermal flu vaccine?After vaccination, avoid excessive massage or friction at the injection site and keep the area dry and clean. If severe redness or pain occurs, seek medical attention promptly. Also, record the vaccination date for future reference.
How effective is the intradermal flu vaccine?The effectiveness of the Intradermal influenza vaccine is comparable to that of traditional intramuscular vaccines, both effectively reducing the risk of influenza infection. Studies indicate an efficacy of approximately 70-90%, though actual results may vary depending on individual health and virus mutation.
Who is suitable for the intradermal flu vaccine?The Intradermal influenza vaccine is suitable for most individuals, including adults and children, but not recommended for those with severe allergies to vaccine components or a history of serious adverse reactions. Pregnant and breastfeeding women should consult their doctor before vaccination to evaluate personal risks and benefits.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
